Make a donation

Pediatric Oncology

Thoracic and vascular surgery

Dermatology, allergology and vascular medicine


Onco-neurology Pitié-Salpêtrière Hospital +33 (0)1 42 16 06 43


Medical Onco-Radiation Therapy


Pneumology Pitié-Salpêtrière Hospital +33 (0)1 42 16 78 84


Urology Pitié-Salpêtrière Hospital +33 (0)1 42 17 71 50
Contact us

Solid and haematological malignancies – JACIE accreditation

The IUC AP-HP Sorbonne University offers multidisciplinary care for solid and haematological malignancies at all ages. In order to ensure the quality and safety of these highly specialised activities, several clinical departments have committed themselves to a quality process of excellence and international recognition of the skills of the teams involved: JACIE* accreditation.

JACIE accreditation currently covers four clinical services that have been involved in the quality accreditation process for almost 10 years:

  • Clinical haematology – Haemobiotherapy at the Pitié-Salpêtrière Hospital
  • Clinical haematology and cell therapy at the Saint-Antoine Hospital
  • Paediatric haematology oncology at the Armand-Trousseau Hospital
  • Medical Oncology and Cellular Therapy at Tenon Hospital

The JACIE programme contributes to the harmonisation and improvement of clinical and medico-technical practices necessary to master the different stages of haematopoietic stem cell transplantation (donor selection and management, stem cell harvesting, preparation/processing of cell therapy products, graft reinjection, recipient follow-up and clinical research data management)

The JACIE standard places particular emphasis on the importance of maintaining the know-how and therefore the skills of medical and non-medical staff. The level of annual activity (number of transplants), the number of staff with specific skills and the experience of the teams in the field of transplantation are all indispensable criteria for claiming this JACIE accreditation.

The JACIE programme requires the implementation of a quality management plan, the ultimate objective of which is the control of risk and the continuous improvement of practices in order to guarantee the quality of patient care. This programme involves other players inside and outside the hospital (pharmacy (chemotherapy, etc.), medical biology laboratory, cell therapy unit, pharmaceutical laboratory for innovative treatments (CAR-T cells), etc.) whose collaboration methods are regularly reviewed and improved.

Like all the actions undertaken by the AP-HP SU IUC, the objective of this accreditation process is to make constant progress in the fight against cancer for patients and their families.

* : JACIE signifie Joint Accreditation Committee for ISCT Europe et EBMT. This is a system set up by two learned societies: the European branch of the International Society for Cell Therapy (ISCT), and the European Group for Blood and Marrow Transplantation (EBMT).